| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| AEON Biopharma, Inc. | Exec VP, CLO & Corp Secretary | Restricted Stock Units | 1.32M | 21 May 2025 | Direct | ||
| AEON Biopharma, Inc. | Exec VP, CLO & Corp Secretary | Stock Option | 481K | 31 Aug 2024 | Direct | ||
| AEON Biopharma, Inc. | Exec VP, CLO & Corp Secretary | Class A Common Stock | 262K | 31 Aug 2024 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| AEON | AEON Biopharma, Inc. | 21 May 2025 | 1 | $0 | 4 | 23 May 2025 | Exec VP, CLO & Corp Secretary |
| AEON | AEON Biopharma, Inc. | 31 Aug 2024 | 2 | $0 | 4 | 04 Sep 2024 | EXEC VP, CLO & CORP SECRETARY |
| AEON | AEON Biopharma, Inc. | 19 Mar 2024 | 1 | $0 | 4 | 21 Mar 2024 | EXEC VP, CLO & CORP SECRETARY |
| AEON | AEON Biopharma, Inc. | 21 Jul 2023 | 4 | $0 | 4 | 24 Jul 2023 | CLO and Corporate Secretary |
| AEON | AEON Biopharma, Inc. | 21 Jul 2023 | 0 | $0 | 3 | 24 Jul 2023 | Exec VP, CLO & Corp Secretary |